Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
---|
01/29/1998 | CA2261291A1 Pasteurization of immunoglobulin solutions |
01/28/1998 | EP0820483A1 Method of photochemical immobilization of ligands using quinones |
01/28/1998 | EP0820463A1 Igf-i purification process |
01/28/1998 | EP0820295A1 Modified lysine or arginine containing proteins and peptides |
01/28/1998 | EP0820285A1 Methods and compositions for lipidization of hydrophilic molecules |
01/28/1998 | EP0754238A4 Determination and identification of active compounds in a compound library |
01/28/1998 | EP0474789B1 Cysteine thiol-protected peptides for use in immunoassays |
01/28/1998 | CN1171791A Purified thrombopoietin and method of making it |
01/28/1998 | CN1171742A Selective acylation of epsilon-amino groups |
01/27/1998 | US5712418 Synthesis and use of amino acid fluorides as peptide coupling reagents |
01/27/1998 | US5712417 Inhibitors of retroviral proteases |
01/27/1998 | US5712370 Erythropoietin (EPO) peptides and antibodies directed against these |
01/27/1998 | US5712367 Coupling with lipophilic substituent |
01/27/1998 | US5712117 Cytoplasmic antiproteinase-2 and coding sequences |
01/27/1998 | US5712101 Glycosylation of hemoglobin, quantification, reaction with epitopes for detection of diabetes |
01/27/1998 | US5711944 Interferon polymer conjugates |
01/27/1998 | US5711931 Technetium-99m labelled peptides for imaging inflammation |
01/22/1998 | WO1998002461A2 Liquid phase peptide syntheses of kl-4 pulmonary surfactant |
01/22/1998 | WO1998002460A1 Selective acylation method |
01/22/1998 | WO1998002457A1 Subunit respiratory syncytial virus vaccine preparation |
01/22/1998 | WO1998002399A1 Method and device for purifying and enriching molecules |
01/22/1998 | CA2260132A1 Method and device for purifying and enriching molecules |
01/21/1998 | EP0819699A1 A process for producing a glycosylated amino compound |
01/21/1998 | EP0819173A1 Mutant of the erythrina caffra type inhibitor and the use of the said mutant for purifying serin proteases |
01/21/1998 | EP0504363B1 PURIFIED IgG ANTIBODIES |
01/21/1998 | CN1037104C Novel cyclosporins |
01/21/1998 | CN1037103C Nevol process for preparing biologically active proteins from human urine |
01/20/1998 | US5710256 Methadone derivatives and protein and polypeptide methadone derivative conjugates and labels |
01/20/1998 | US5710253 Method for decoloring human serum albumin |
01/20/1998 | US5710251 Ion exchanging with anions and cations and applying hydroxyapatite chromatography |
01/20/1998 | US5710249 Amino acids and processes for making peptides using same |
01/20/1998 | US5710247 Process and intermediates for the synthesis of LHRH antagonists |
01/20/1998 | US5710246 Coupling oligopeptides; deprotecting |
01/20/1998 | US5710245 Alpha-helix mimetics and methods relating thereto |
01/20/1998 | US5710131 Protein isolated from extract of hirudo medicinalis (leech) |
01/20/1998 | US5710027 Process and vector for expressing alpha-interferon in E. coli |
01/20/1998 | US5710026 Cytoplasmic antiproteinase-2 and cytoplasmic antiproteinase-3 and coding sequences |
01/20/1998 | US5709861 Compositions for the delivery of antigens |
01/15/1998 | WO1998001757A1 Labelling and selection of molecules |
01/15/1998 | WO1998001560A1 Modified protein g and fragments thereof |
01/15/1998 | WO1998001555A2 Truncated soluble tumor necrosis factor type-i and type-ii receptors |
01/15/1998 | WO1998001482A1 Removal of proteins from aqueous media by precipitation |
01/15/1998 | WO1998001464A1 Methods for the selective separation of organic components from biological fluids |
01/15/1998 | WO1998001406A1 Enzymatically removable linkers for solid phase synthesis |
01/15/1998 | WO1998001221A1 Electrochemical solid phase synthesis of polymers |
01/15/1998 | DE19628171A1 Apparatus for enriching charged molecules, especially nucleic acids or proteins |
01/15/1998 | CA2259615A1 Removal of proteins from aqueous media by precipitation |
01/15/1998 | CA2258551A1 Enzymatically removable linkers for solid phase synthesis |
01/14/1998 | EP0818744A2 Process for selecting candidate drug compounds |
01/14/1998 | EP0818467A2 Aligned peptide array and a rational and rapid method for the detection of a binding or interaction site of a protein by using the same |
01/14/1998 | EP0818466A2 Purified, biologically active bacterially produced recombinant human CSF-1 |
01/14/1998 | EP0817846A1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies |
01/14/1998 | EP0817796A1 Cyclic peptide nuclei and derivatives thereof |
01/14/1998 | EP0817794A1 Method for protein folding |
01/14/1998 | CN1169999A Method for preparing oligoreptide-aldehyde |
01/14/1998 | CN1169998A Process of extracting and purifying recombined protein |
01/13/1998 | US5708163 Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof |
01/13/1998 | US5708153 Preparing a library |
01/13/1998 | US5708148 Mutants of escherichia coli cells, denaturing polypeptides, refolding and incubation |
01/13/1998 | US5708146 Antibodies and drugs |
01/13/1998 | US5708140 Production of proteins using 7B2 protein |
01/13/1998 | US5708138 Immunoreactive peptides of apo(a) |
01/13/1998 | US5708134 Human AlaGlu-IGF-1 |
01/13/1998 | US5707805 Assay for detecting keratinocyte growth factor (KGF) and its activity |
01/08/1998 | WO1998000443A1 Thrombin inhibitors |
01/08/1998 | WO1998000442A1 Serine protease inhibitors |
01/08/1998 | WO1998000441A1 A method for chromatographic removal of prions |
01/08/1998 | WO1998000154A1 Process for separating alpha-1-proteinase inhibitor from cohn fraction iv1 +iv4 paste |
01/08/1998 | WO1997041824A3 Antiangiogenic peptides derived from plasminogen |
01/08/1998 | WO1997033995A3 Extracellular matrix signalling molecules |
01/08/1998 | DE19626762A1 Enzymatisch spaltbare Linker für Festphasensynthesen Enzymatically cleavable linker for solid-phase synthesis |
01/08/1998 | DE19626750A1 Preparative isolation of bio-molecules on carrier having specific binding component |
01/08/1998 | CA2489773A1 Process for separating alpha-1-proteinase inhibitor from cohn fraction iv1 + iv4 paste |
01/08/1998 | CA2258634A1 Serine protease inhibitors |
01/07/1998 | EP0816852A1 Process for measuring a collagen-binding substance, especially of the activity of an adhesion-protein |
01/07/1998 | EP0816509A2 Thermostabilization, osmoprotection, and protection against desiccation of enzymes, cell components and cells by mannosyl-glycerate |
01/07/1998 | EP0816506A1 System for the expression of heterologous antigens as fusion proteins |
01/07/1998 | EP0816504A2 Platelet activating factor acetylhdrolase, and gene thereof |
01/07/1998 | EP0816496A2 T-cells specific for kidney carcinoma |
01/07/1998 | EP0816379A2 DNA binding oligomers |
01/07/1998 | EP0816377A2 Peptides which bind to prothrombin and thrombin |
01/07/1998 | EP0815873A1 Selective stabilization of proteins by binding to an immobilised affinity ligandduring viral |
01/07/1998 | EP0815141A1 Antibodies active against a fusion polypeptide comprising a histidine portion |
01/07/1998 | EP0815138A1 Stable polymerized hemoglobin blood-substitute |
01/07/1998 | EP0815130A1 Casein phosphopeptide, casein containing same and process for the preparation thereof |
01/07/1998 | EP0815122A1 Process for preparation of pure cyclosporin chromatographically using an eluent consisting essentially of high pressure carbon dioxide |
01/07/1998 | EP0815121A1 Modified-affinity streptavidin |
01/07/1998 | EP0778847A4 Immunostimulatory agents |
01/07/1998 | EP0764047A4 Polymeric microbeads and method of preparation |
01/07/1998 | EP0730604A4 Surface membrane proteins and their effect on immune response |
01/07/1998 | EP0406357B1 Functional recombinantly prepared synthetic protein polymer |
01/07/1998 | CN1169734A Method for purifying keratinocyte growth factors |
01/07/1998 | CN1169729A Modulators functions of FAS/APOL receptors |
01/07/1998 | CN1169436A Synthesized fructosamine and preparation method thereof |
01/07/1998 | CN1036934C Process for preparing isohirudins with improved stability |
01/06/1998 | US5705612 NEF peptide encoded by human immunodefiency virus type 1 (HIV-1) |
01/06/1998 | US5705610 Suspension solution, coupling, withdrawal and mixing |
01/06/1998 | US5705608 Polypeptides with dna sequence codes |
01/06/1998 | US5705585 Aminimide-containing molecules and materials as molecular recognition agents |
01/06/1998 | US5705486 Anticoagulants for blood disorders |